Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

  • ME Gore
  • , CL Griffin
  • , B Hancock
  • , PM Patel
  • , L Pyle
  • , M Aitchison
  • , Nicholas James
  • , RTD Oliver
  • , J Mardiak
  • , T Hussain
  • , R Sylvester
  • , MKB Parmar
  • , P Royston
  • , PFA Mulders

Research output: Contribution to journal › Article

88 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science